T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.47% |
| 2 | Healthcare | 18.68% |
| 3 | Consumer Discretionary | 13.32% |
| 4 | Financials | 12.13% |
| 5 | Communication Services | 10.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Commercial Metals
CMC
$7.99B
| $3.21M | ﹤0.01% |
203,006
+49,766
| +32% | +$948K |
|
1402
Jack in the Box
JACK
$344M
| $3.18M | ﹤0.01% |
90,779
+19,146
| +27% | +$1.3M |
|
|
MPT
1403
Medical Properties Trust
MPT
$2.51B
| $3.16M | ﹤0.01% |
182,881
+20,214
| +12% | +$423K |
|
1404
SEI Investments
SEIC
$12.8B
| $3.15M | ﹤0.01% |
68,060
-8,074
| -11% | -$480K |
|
1405
Macy's
M
$6.27B
| $3.14M | ﹤0.01% |
639,863
+52,149
| +9% | +$707K |
|
1406
Madrigal Pharmaceuticals
MDGL
$11.6B
| $3.12M | ﹤0.01% |
46,718
-701
| -1% | -$58.4K |
|
1407
Universal Display
OLED
$4.15B
| $3.11M | ﹤0.01% |
23,568
-1,690
| -7% | -$291K |
|
1408
VICI Properties
VICI
$29B
| $3.11M | ﹤0.01% |
186,673
+20,103
| +12% | +$470K |
|
1409
Star Group
SGU
$418M
| $3.09M | ﹤0.01% |
401,325
| – | – |
|
1410
Passage Bio
PASG
$14.5M
| $3.06M | ﹤0.01% |
+9,714
| New | +$3.04M |
|
1411
CareDx
CDNA
$2.39B
| $3.05M | ﹤0.01% |
+139,518
| New | +$3.13M |
|
1412
OraSure Technologies
OSUR
$268M
| $3.02M | ﹤0.01% |
280,954
+83,204
| +42% | +$595K |
|
1413
Badger Meter
BMI
$3.77B
| $3.01M | ﹤0.01% |
56,132
+1,980
| +4% | +$121K |
|
1414
Zillow
Z
$7.87B
| $2.99M | ﹤0.01% |
82,950
-44,701
| -35% | -$2.06M |
|
1415
Toronto Dominion Bank
TD
$204B
| $2.96M | ﹤0.01% |
70,424
+5,885
| +9% | +$302K |
|
1416
Oshkosh
OSK
$9.53B
| $2.95M | ﹤0.01% |
45,799
-688
| -1% | -$53.9K |
|
1417
New Jersey Resources
NJR
$5.65B
| $2.94M | ﹤0.01% |
86,462
+909
| +1% | +$35.5K |
|
|
EV
1418
DELISTED
Eaton Vance Corp.
EV
| $2.93M | ﹤0.01% |
90,979
+2,375
| +3% | +$101K |
|
|
GMS
1419
DELISTED
GMS Inc
GMS
| $2.91M | ﹤0.01% |
185,271
+25,976
| +16% | +$615K |
|
|
HRC
1420
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $2.89M | ﹤0.01% |
28,722
-1,122
| -4% | -$116K |
|
1421
American Homes 4 Rent
AMH
$12.3B
| $2.88M | ﹤0.01% |
124,344
-23,008
| -16% | -$608K |
|
1422
Commerce Bancshares
CBSH
$8.65B
| $2.86M | ﹤0.01% |
76,146
+1,117
| +1% | +$52.9K |
|
|
SILK
1423
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $2.86M | ﹤0.01% |
90,870
-5,403
| -6% | -$216K |
|
1424
American Financial Group
AFG
$12B
| $2.84M | ﹤0.01% |
40,568
+873
| +2% | +$84.3K |
|
1425
Reinsurance Group of America
RGA
$16.2B
| $2.84M | ﹤0.01% |
33,745
-539
| -2% | -$70.3K |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.